Rate My Professor Feng Wang

Feng Wang is a Professor at Shanghai Jiao Tong University School of Medicine. He earned his undergraduate degree from the School of Life Sciences at Beijing Normal University in 2005 and his Ph.D. from the joint program between Beijing Normal University and the National Institute of Biological Sciences, Beijing, in 2010. From 2010 to 2016, he conducted postdoctoral research at Stanford University under Professor Mark M. Davis. Wang leads the Immune Cell Signaling and Metabolism Research Group at the Shanghai Institute of Immunology. His research focuses on the mechanisms of immune recognition, signal transduction, and metabolic regulation in T lymphocytes, as well as their roles in cancer, infection, and autoimmune diseases. He employs techniques from immunology, molecular cell biology, biophysics, and biochemistry to investigate natural metabolite regulation of T cell recognition and signaling, T cell receptor repertoires in tumor and infection immunity, and mechanisms of antitumor and autoimmune responses induced by immune checkpoint inhibitors.

Wang has published as corresponding or first author in journals including Nature Immunology (2016), PNAS (2018, 2020), BMC Biology (2020), Cell Discovery (2021), Theranostics (2021), and EMBO Journal (2022). He has been selected for national high-level young talent programs, Shanghai distinguished professor, and Shanghai high-level young talent and Pujiang talent plans. In recent years, he has led nine national-level projects, including the National Key R&D Program and National Natural Science Foundation of China grants, and four provincial/ministerial projects funded by the Shanghai Science and Technology Commission and Shanghai Health Commission.